Status:
COMPLETED
MEV to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus
Lead Sponsor:
University Hospital of North Norway
Conditions:
Shoulder Disease
Anesthesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The investigators have recently shown that LSIB in combination with a suprascapular and a cervical plexus block is a very good alternative for arthroscopic shoulder surgery. However, the investigators...
Detailed Description
The MEV for a successful block in 50% of the participants will be determined by using the staircase up-and-down method introduced by Dixon and Massey. Logistic regression and probit transformation wil...
Eligibility Criteria
Inclusion
- . Inclusion criteria are American Society of Anesthesiologists (ASA) physical status I-III, age between 18 and 70 years and body mass index (BMI) between 20 and 35 kg/m2.
Exclusion
- Exclusion criteria are pregnancy, patients with contraindications to regional anesthesia, allergy to LAs, patients taking opioids regularly due to chronic pain, use of anticoagulation drugs other than acetylsalicylic acid or dipyridamole, atrioventricular block, diabetes.
Key Trial Info
Start Date :
October 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03329456
Start Date
October 30 2017
End Date
April 1 2018
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Troms, Norway, 9038